OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 6.86
-0.29 (-4.06%)
Jul 24, 2026, 4:53 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 100.44 million as of July 24, 2026. Its market cap has increased by 35.04% in one year.
Market Cap
100.44M
Enterprise Value
107.01M
Revenue
71.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.86
ChartMarket Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has increased from 89.02M to 100.44M, an increase of 12.83%. That is a compound annual growth rate of 2.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 100.44M | 17.49% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xintela AB | 162.35M |
| Diamyd Medical AB | 159.63M |
| Alzinova AB | 151.98M |
| Biovica International AB | 143.04M |
| Nanologica AB | 141.37M |
| Active Biotech AB | 134.44M |
| NextCell Pharma AB | 127.91M |
| Annexin Pharmaceuticals AB | 88.24M |